Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
about
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitusCurrent Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve OutcomesRecent advances in managing and understanding diabetic nephropathyClinical Predictive Factors in Diabetic Kidney Disease ProgressionWhy do some patients with type 1 diabetes live so long?Present and future in the treatment of diabetic kidney diseaseInsulin sensitivity and complications in type 1 diabetes: New insightsRole of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetesToxic stress, inflammation and symptomatology of chronic complications in diabetesEpigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease?Interventions to improve patients' compliance with therapies aimed at lowering glycated hemoglobin (HbA1c) in type 1 diabetes: systematic review and meta-analyses of randomized controlled clinical trials of psychological, telecare, and educational iImprovements in the Management of Diabetic NephropathyMini-review: emerging roles of microRNAs in the pathophysiology of renal diseasesThe Genetic Landscape of Renal Complications in Type 1 Diabetes.Differential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 DiabetesClinical therapeutic strategies for early stage of diabetic kidney disease.Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.Nursing's role in courage development in patients facing complications of diabetes.Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacyTime to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry.Human islet xenotransplantation in rodents: A literature review of experimental model trends.Impact of creatinine methodology on glomerular filtration rate estimation in diabetes.The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic ComplicationsPredictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiativeSlowing progression of chronic kidney diseaseNephropathy in youth and young adults with type 2 diabetesTargeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: findings from the DCCT/EDICDiabetic kidney disease in children and adolescents.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Renal outcomes in patients with type 1 diabetes and macroalbuminuriaDiabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications studyImproved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.Prevention of chronic kidney disease and subsequent effect on mortality: a systematic review and meta-analysis.Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.Fasting blood glucose--a missing variable for GFR-estimation in type 1 diabetes?Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES StudyAssociation between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease.
P2860
Q24200376-370C59D2-8CEA-4DBC-9B06-00179EBA4E96Q26744419-596BD262-5988-48D4-BEAF-9672E2157956Q26745900-34785C66-B09C-4274-BE33-148EBC71C989Q26749494-45DA1E4C-9236-4C55-A5BC-A67BBE0C4058Q26858877-2F7669C3-60BF-4A06-9A38-AEE0CB33B6ECQ26864133-6F52C60E-0E24-4CD7-A416-1538D9540B0BQ27000205-1E467366-3188-476C-BADC-E40071254CE0Q27004274-8E239828-A226-40F7-A769-68C42CBCB3ADQ27011633-7D377F45-2494-4C34-8563-2B0E90FA1E88Q27013782-98685B53-CB9E-428D-869D-125F2843EE26Q28072157-26F999B5-E5F9-41DD-AA28-B7E7FEF04F43Q28080717-4067B8DF-C677-409B-BFD7-A94123F89E25Q28354033-BBA1F43B-81A0-46B6-9AAA-6D58C5C3E194Q30275890-31398AA0-00C7-4779-A7A8-C31916845142Q30300141-18541B6A-9617-4F36-B283-BCFDD288FC29Q30363683-82D4D601-A41C-405A-B6FA-869F039C0542Q30371076-B4A45923-9F32-45BE-B1DB-E40E9C8505BFQ30421781-68E4D45B-0AD7-4A36-9863-F5C97BFAED9BQ30714941-AB9C93B5-9BC8-442D-9AA8-861F179A6172Q31060724-A8D1A874-4815-487D-87FA-2EEB9C3EDF94Q33592673-6EC31D04-00A7-45FE-A59F-15B68A29CF14Q33706769-CD07F6C1-3C41-452F-8A7F-A049CD3AA2D8Q33749208-82F72D3E-0E4E-4A83-9417-0A9D0642BB1DQ33789640-E9406446-D8AD-428B-A19F-05E5A0F33AEBQ33873241-31545076-8EEF-4D46-9C61-03DB86129FC3Q33903763-AE5426EF-A452-447E-B194-42879F96D073Q34071861-98C12E13-FC8B-4FD3-9F0E-51AAEF719210Q34130959-106B8A06-4B25-41E7-A6D0-A53F8B7A4AA5Q34214578-7998131F-C937-4B11-AA91-9D9D65644BF3Q34219439-8B8CD037-6497-4691-B447-1AFEEDB90A2DQ34260068-77379BC4-3F22-49C5-BBA9-990264FB79F2Q34429278-55340B36-96B0-4F83-8E93-96C1D2737793Q34433105-A21D3F03-393B-4EA4-8EA6-7CE131604E03Q34568748-57E04A87-A724-4D43-AE50-2A5F9EDB8A4BQ34609759-DEC233E9-54AC-4885-B8B5-2384BC5241ADQ34979484-724631BD-3561-4BBC-8A49-6CC2FE5124BDQ35012749-0A7AFFE6-130D-46ED-B6E6-98F56E404CBBQ35159815-A1795B6F-DFD9-4635-B2A4-8631174032D2Q35344925-02423BB6-1AF6-4E50-AB00-0098ECE30646Q35587399-6C21ECAD-4289-4131-BFEF-DA04F02F6C60
P2860
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
@ast
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
@en
type
label
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
@ast
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
@en
prefLabel
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
@ast
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
@en
P2093
P2860
P356
P1476
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
@en
P2093
DCCT/EDIC Research Group
Ian H de Boer
Mark E Molitch
Michael W Steffes
Patricia A Cleary
Wanjie Sun
P2860
P304
P356
10.1056/NEJMOA1111732
P407
P577
2011-11-12T00:00:00Z